Professor Dr. Robert Schiestl Ph. D. Joins Pacific Software Inc. as Chief Science Advisor (CSA)
Pacific Software Inc. (OTC:PFSF) has appointed Professor Dr. Robert Schiestl Ph.D. as its Chief Science Advisor (CSA). Dr. Schiestl, a distinguished scientist with over 200 peer-reviewed publications and 16 patents, brings extensive expertise in molecular toxicology, cancer prevention, and genomics. His research focuses on genetic stability and strategies to prevent genetic diseases and cancer, aligning with Pacific Software's mission to develop innovative skincare products and science-based dietary supplements.
Dr. Schiestl's background includes positions at Harvard School of Public Health and UCLA, where he is currently Professor Emeritus. His work on oxidative stress and its health impacts is particularly relevant to Pacific Software's objectives. CEO Harrysen Mittler expressed enthusiasm about Dr. Schiestl's potential contributions to advancing the company's cosmeceutical technology and supplement offerings.
Pacific Software Inc. (OTC:PFSF) ha nominato il Professor Dr. Robert Schiestl Ph.D. come Chief Science Advisor (CSA). Il Dr. Schiestl, un illustre scienziato con oltre 200 pubblicazioni sottoposte a revisione tra pari e 16 brevetti, porta con sé una vasta esperienza in tossicologia molecolare, prevenzione del cancro e genomica. La sua ricerca si concentra sulla stabilità genetica e sulle strategie per prevenire le malattie genetiche e il cancro, in linea con la missione di Pacific Software di sviluppare prodotti per la cura della pelle innovativi e integratori alimentari basati sulla scienza.
Il background del Dr. Schiestl include posizioni presso la Harvard School of Public Health e UCLA, dove attualmente è Professor Emeritus. Il suo lavoro sullo stress ossidativo e sui suoi impatti sulla salute è particolarmente rilevante per gli obiettivi di Pacific Software. Il CEO Harrysen Mittler ha espresso entusiasmo riguardo ai potenziali contributi del Dr. Schiestl per far progredire la tecnologia cosmeceutica e l'offerta di integratori dell'azienda.
Pacific Software Inc. (OTC:PFSF) ha nombrado al Profesor Dr. Robert Schiestl Ph.D. como su Chief Science Advisor (CSA). El Dr. Schiestl, un destacado científico con más de 200 publicaciones revisadas por pares y 16 patentes, aporta una amplia experiencia en toxicología molecular, prevención del cáncer y genómica. Su investigación se centra en la estabilidad genética y en estrategias para prevenir enfermedades genéticas y cáncer, alineándose con la misión de Pacific Software de desarrollar productos innovadores para el cuidado de la piel y suplementos dietéticos basados en la ciencia.
El historial del Dr. Schiestl incluye puestos en la Harvard School of Public Health y UCLA, donde actualmente es Profesor Emérito. Su trabajo sobre el estrés oxidativo y sus impactos en la salud es particularmente relevante para los objetivos de Pacific Software. El CEO Harrysen Mittler expresó entusiasmo por las potenciales contribuciones del Dr. Schiestl para avanzar en la tecnología cosmeceutica y la oferta de suplementos de la empresa.
Pacific Software Inc. (OTC:PFSF)는 로버트 시에스틀 박사(Professor Dr. Robert Schiestl Ph.D.)를 최고 과학 고문(Chief Science Advisor, CSA)으로 임명했습니다. 시에스틀 박사는 200편 이상의 동료 검토 논문과 16개 특허를 보유한 저명한 과학자로, 분자 독성학, 암 예방 및 유전체학에 대한 폭넓은 전문성을 지니고 있습니다. 그의 연구는 유전적 안정성과 유전 질병 및 암 예방 전략에 중점을 두고 있으며, 이는 Pacific Software의 혁신적인 스킨케어 제품과 과학 기반의 건강 보조 식품 개발 미션과 일치합니다.
시에스틀 박사는 현재 명예 교수직을 맡고 있는 하버드 공공 보건학교와 UCLA에서 근무한 경험이 있습니다. 산화 스트레스와 건강에 미치는 영향에 대한 그의 연구는 Pacific Software의 목표에 특히 관련성이 높습니다. CEO 해리센 미틀러는 시에스틀 박사가 회사의 코스메슈티컬 기술 및 보충제 제품 향상에 기여할 가능성에 대해 기대감을 표했습니다.
Pacific Software Inc. (OTC:PFSF) a nommé le Professeur Dr. Robert Schiestl Ph.D. en tant que Conseiller scientifique en chef (CSA). Le Dr. Schiestl, un scientifique éminent avec plus de 200 publications évaluées par des pairs et 16 brevets, apporte une expertise considérable en toxicologie moléculaire, prévention du cancer et génomique. Ses recherches portent sur la stabilité génétique et les stratégies de prévention des maladies génétiques et du cancer, en accord avec la mission de Pacific Software de développer des produits innovants pour les soins de la peau et des compléments alimentaires basés sur la science.
Le parcours du Dr. Schiestl comprend des postes à la Harvard School of Public Health et à UCLA, où il est actuellement Professeur Émérite. Son travail sur le stress oxydatif et ses impacts sur la santé est particulièrement pertinent pour les objectifs de Pacific Software. Le PDG Harrysen Mittler a exprimé son enthousiasme concernant les contributions potentielles du Dr. Schiestl pour faire progresser la technologie cosméceutique et l'offre de compléments alimentaires de l'entreprise.
Pacific Software Inc. (OTC:PFSF) hat Professor Dr. Robert Schiestl Ph.D. zum Chief Science Advisor (CSA) ernannt. Dr. Schiestl, ein angesehener Wissenschaftler mit über 200 begutachteten Publikationen und 16 Patenten, bringt umfangreiche Expertise in molekularer Toxikologie, Krebsprävention und Genomik mit. Seine Forschung konzentriert sich auf genetische Stabilität und Strategien zur Prävention genetischer Erkrankungen und Krebs, was im Einklang mit der Mission von Pacific Software steht, innovative Hautpflegeprodukte und wissenschaftlich fundierte Nahrungsergänzungsmittel zu entwickeln.
Der Hintergrund von Dr. Schiestl umfasst Positionen an der Harvard School of Public Health und der UCLA, wo er derzeit als Professor Emeritus tätig ist. Seine Arbeit zum oxidativen Stress und dessen Auswirkungen auf die Gesundheit ist für die Ziele von Pacific Software besonders relevant. CEO Harrysen Mittler äußerte sich begeistert über Dr. Schiestls mögliche Beiträge zur Weiterentwicklung der Kosmetikum-Technologie und des Angebots an Nahrungsergänzungsmitteln des Unternehmens.
- Appointment of highly qualified Chief Science Advisor with extensive research background
- Alignment of Dr. Schiestl's expertise with company's focus on skincare and dietary supplements
- Potential for advancing company's cosmeceutical technology and supplement offerings
- None.
DANA POINT, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Pacific Software Inc.(OTC:PFSF), an emerging skincare, and aesthetics company known for its patented cosmeceutical technology Dermatrix and science-based dietary supplements, is excited to announce the appointment of Professor Dr. Robert Schiestl Ph.D. as its Chief Science Advisor (CSA), effective immediately.
Dr. Robert Schiestl is a distinguished scientist who received his Ph.D. from the University of Vienna, Austria with an extensive background in molecular toxicology, cancer prevention, and genomics. He was previously Assistant and Associate Professor in the Department of Cancer Research and later Toxicology at the Harvard School of Public Health. He is currently Professor Emeritus of Pathology, Environmental Health Sciences and Radiation Oncology at UCLA. He was a Director of the UCLA Center for Environmental Genomics, member of the UCLA Cancer Center and Occupational and Environmental Health Sciences. He was also a member of the Interdepartmental Program in molecular Toxicology (advisory committee) at UCLA. Dr. Schiestl has authored over 200 peer-reviewed publications and has been recognized with numerous awards for his groundbreaking research and contributions to science.
Dr. Schiestl's work focuses on the mechanisms of genetic stability and the development of strategies to prevent genetic diseases and cancer. His research has provided significant insights into the field of oxidative stress and its impact on health, which aligns perfectly with the company’s mission to develop innovative skincare products and science-based dietary supplements.
Dr. Schiestl’s Achievements and Contributions Include:
- Over 200 peer-reviewed publications in prestigious scientific journals, 9 press releases and 16 patents and 6 companies.
- Recipient of numerous awards including Outstanding Leadership Award in Healthcare 2022, Outstanding Visionary Award in Healthcare 2023, Outstanding Organization Award in Healthcare 2024, Outstanding Education Award 2023, The Outstanding MORE Leadership Award (Money and Real Estate) in 2023, Outstanding CXO Award 2024 as best CEO, the Outstanding Leadership Award in Internet 2024, The Best Speakership Award at The International Conference on Nursery, Patient Safety and Healthcare 2023.
- Pioneering research in genetic stability and cancer prevention and Health.
- Development of novel strategies to combat oxidative stress-related health issues.
Harrysen Mittler, CEO stated: "We are thrilled to welcome Dr. Robert Schiestl to our team as our Chief Science Advisor. His unparalleled expertise and visionary approach to scientific research will be invaluable as we continue to advance our cosmeceutical technology and dietary supplements to commercial status. His insights and guidance may play a crucial role in shaping the future of our innovations and supplement offerings."
About Pacific Software Inc.
Pacific Software Inc. is an emerging cosmetics and aesthetics company developing skincare products featuring its patented cosmeceutical technology known as Dermatrix. Additionally, the company expects to produce science-based dietary supplements designed to promote overall health and wellness. Recently the company announced the acquisition of a science based dietary supplement supporting brain health and memory function. The supplement was sold over a period of 8 years under the brand names of SuppleMEM AD™ and A.L.Z. Defense™ featuring a formula tested extensively by leading Alzheimer’s researchers. The Company intends to resurrect these brand names and commercial product applications in the USA and Mexico.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, PFSF's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners, and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various scientific and manufacturing programs, changes in future customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond PFSF's control. Except as may be required by law, Pacific Software, Inc. undertakes no obligation, and does not intend, to update these forward-looking statements after the date of this release.
Contact:
Harrysen Mittler, CEO
Tel: (310) 600-5064
E-mail: info@pacificsoftwareinc.com
Website: pacificsoftwareinc.com
FAQ
Who is the new Chief Science Advisor for Pacific Software Inc. (PFSF)?
What is Dr. Robert Schiestl's background and expertise relevant to Pacific Software Inc. (PFSF)?
How many peer-reviewed publications and patents does Dr. Robert Schiestl have?
What is Pacific Software Inc.'s (PFSF) main business focus?
